Amarin vows to challenge Vascepa patent ruling
04-09-2020
No fees award for PTAB proceedings, rules Fed Circuit
05-06-2020
Pavel Kapysh / Shutterstock.com
In a victory for pharmaceutical company Amneal, a Delaware court has invalidated claims of three patents covering Noven Pharmaceuticals’ Minivelle oestrogen product.
You need a subscription to continue reading this content.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
Amneal, Noven Pharmaceuticals, Minivelle, oestrogen patch, patent infringement, Chief Judge Leonard Stark, FDA
